Eutropics Pharmaceuticals, Inc. - Product Pipeline Analysis, 2014 Update

Eutropics Pharmaceuticals, Inc. - Product Pipeline Analysis, 2014 Update

Regular price $750.00 Sale

Published on Jun 06, 2014 - 28 pages

Eutropics Pharmaceuticals, Inc. (Eutropics) is a diagnostic service provider. The company develops a novel test to guide cancer treatment. Its PraediCare Dx is a technology to improve treatment for leukemia, myeloma, lymphoma and other type of cancers. The company's BH3 profiling assay provides a biomarker that is used in the pre clinical development of experimental drugs and guides the use of marketed cancer drugs. Eutropics provides tests for established and experimental cancer therapies. It offers therapies for the treatment of blood cancers, small cell lung cancers and ovarian cancer. The company provides therapeutics for cancer patients Eutropics is headquartered in Cambridge, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Eutropics Pharmaceuticals, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Table of Contents

Table of Contents
Table of Contents
List of Tables
List of Figures
Eutropics Pharmaceuticals, Inc. Company Snapshot
Eutropics Pharmaceuticals, Inc. Company Overview
Key Information
Eutropics Pharmaceuticals, Inc. Pipeline Products and Clinical Trials Overview
Eutropics Pharmaceuticals, Inc. - Pipeline Analysis Overview
Key Facts
Eutropics Pharmaceuticals, Inc. - Major Products and Services
Eutropics Pharmaceuticals, Inc. Pipeline Products by Development Stage
Eutropics Pharmaceuticals, Inc. Pipeline Products Overview
CDK-1 In Companion Diagnostic Assay - Multiple Myeloma
CDK-1 In Companion Diagnostic Assay - Multiple Myeloma Product Overview
Cytarabine Companion Diagnostic Assay - Acute Myeloid Leukemia
Cytarabine Companion Diagnostic Assay - Acute Myeloid Leukemia Product Overview
Diagnostic Test - Acute Lymphoid Leukemia
Diagnostic Test - Acute Lymphoid Leukemia Product Overview
Diagnostic Test - Chronic Lymphoid Leukemia
Diagnostic Test - Chronic Lymphoid Leukemia Product Overview
Diagnostic Test - Diffuse Large B-Cell
Diagnostic Test - Diffuse Large B-Cell Product Overview
EU-4030 Companion Diagnostic Assay - AML
EU-4030 Companion Diagnostic Assay - AML Product Overview
EU-4030 Companion Diagnostic Assay - Multiple Myeloma
EU-4030 Companion Diagnostic Assay - Multiple Myeloma Product Overview
EU-5013 Companion Diagnostic Assay - AML
EU-5013 Companion Diagnostic Assay - AML Product Overview
EU-5013 Companion Diagnostic Assay - Multiple Myeloma
EU-5013 Companion Diagnostic Assay - Multiple Myeloma Product Overview
HDAC-In Companion Diagnostic Assay - Acute Myeloid Leukemia
HDAC-In Companion Diagnostic Assay - Acute Myeloid Leukemia Product Overview
HDAC-In Companion Diagnostic Assay - Multiple Myeloma
HDAC-In Companion Diagnostic Assay - Multiple Myeloma Product Overview
Velcade Companion Diagnostic Assay
Velcade Companion Diagnostic Assay Product Overview
Eutropics Pharmaceuticals, Inc. - Key Competitors
Eutropics Pharmaceuticals, Inc. - Key Employees
Eutropics Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
Eutropics Pharmaceuticals, Inc., Recent Developments
Sep 18, 2012: Eutropics Pharmaceuticals Signs Contract To Develop Companion Diagnostic For Guiding AML Treatments With NCI
May 08, 2012: Eutropics Pharma Receives US Patent For Novel Diagnostic Method
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Eutropics Pharmaceuticals, Inc., Key Facts
Eutropics Pharmaceuticals, Inc. Pipeline Products and Clinical Trials Overview
Eutropics Pharmaceuticals, Inc. Pipeline Products by Equipment Type
Eutropics Pharmaceuticals, Inc. Pipeline Products by Indication
Eutropics Pharmaceuticals, Inc., Key Facts
Eutropics Pharmaceuticals, Inc., Major Products and Services
Eutropics Pharmaceuticals, Inc. Number of Pipeline Products by Development Stage
Eutropics Pharmaceuticals, Inc. Pipeline Products Summary by Development Stage
CDK-1 In Companion Diagnostic Assay - Multiple Myeloma - Product Status
CDK-1 In Companion Diagnostic Assay - Multiple Myeloma - Product Description
Cytarabine Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Status
Cytarabine Companion Diagnostic Assay - Acute Myeloid Leukemia - Product Description
Diagnostic Test - Acute Lymphoid Leukemia - Product Status


Companies Mentioned:

Eutropics Pharmaceuticals, Inc.